Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Schuger

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
JACC. Clinical Electrophysiology|November 30, 2023
Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular TachyarrhythmiasBartosz Krzowski, Valentina Kutyifa, Margot Vloka, et al.
American Heart Journal|June 20, 2017
Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocolValentina Kutyifa, Christopher Beck, Mary W Brown, et al.
The New England Journal of Medicine|November 8, 2012
Reduction in inappropriate therapy and mortality through ICD programmingArthur J Moss, Claudio Schuger, Christopher A Beck, et al.
Circulation|December 10, 2008
Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trialWilliam G Stevenson, David J Wilber, Andrea Natale, et al.
Journal of the American Heart Association|June 4, 2015
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research NetworkFrederick A Masoudi, Alan S Go, David J Magid, et al.
Circulation. Arrhythmia and Electrophysiology|August 20, 2014
Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT)Anne-Christine Ruwald, Claudio Schuger, Arthur J Moss, et al.
Structural Heart : the Journal of the Heart Team|September 18, 2024
The Transcatheter Aortic Valve Replacement-Conduction Study: The Value of the His-Ventricular Interval in Risk Stratification for Post-TAVR Atrioventricular-BlockMohamad Raad, Joshua Greenberg, Mahmoud Altawil, et al.
Journal of the American Geriatrics Society|March 21, 2019
Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter-Defibrillator TherapiesAlexandra M Hajduk, Jerry H Gurwitz, Grace Tabada, et al.
Journal of the American College of Cardiology|August 4, 2018
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID TrialWojciech Zareba, James P Daubert, Christopher A Beck, et al.
Journal of the American Heart Association|March 28, 2018
Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research NetworkRobert T Greenlee, Alan S Go, Pamela N Peterson, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
JACC. Clinical Electrophysiology|November 30, 2023
Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular TachyarrhythmiasBartosz Krzowski, Valentina Kutyifa, Margot Vloka, et al.
American Heart Journal|June 20, 2017
Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocolValentina Kutyifa, Christopher Beck, Mary W Brown, et al.
The New England Journal of Medicine|November 8, 2012
Reduction in inappropriate therapy and mortality through ICD programmingArthur J Moss, Claudio Schuger, Christopher A Beck, et al.
Circulation|December 10, 2008
Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trialWilliam G Stevenson, David J Wilber, Andrea Natale, et al.
Journal of the American Heart Association|June 4, 2015
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research NetworkFrederick A Masoudi, Alan S Go, David J Magid, et al.
Circulation. Arrhythmia and Electrophysiology|August 20, 2014
Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT)Anne-Christine Ruwald, Claudio Schuger, Arthur J Moss, et al.
Structural Heart : the Journal of the Heart Team|September 18, 2024
The Transcatheter Aortic Valve Replacement-Conduction Study: The Value of the His-Ventricular Interval in Risk Stratification for Post-TAVR Atrioventricular-BlockMohamad Raad, Joshua Greenberg, Mahmoud Altawil, et al.
Journal of the American Geriatrics Society|March 21, 2019
Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter-Defibrillator TherapiesAlexandra M Hajduk, Jerry H Gurwitz, Grace Tabada, et al.
Journal of the American College of Cardiology|August 4, 2018
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID TrialWojciech Zareba, James P Daubert, Christopher A Beck, et al.
Journal of the American Heart Association|March 28, 2018
Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research NetworkRobert T Greenlee, Alan S Go, Pamela N Peterson, et al.
Pageof 5